5 
the perfonnance of local IBCs in reviewing physical oontaiment 
facilities." 
Dr. Fredridcaon wrote further in the Federed Register of Novenjber 21 , 1980 (45 
PR 77380): 
"In accordance with the reocrnmendation of the RAC, the Working Group 
will not be involved in pre-review of individu^d. e^lications. lb 
assist in its finction of advising the RAC on the performance of local 
IBCs in reviewing physic^d containment facilities and on future 
revisions of the Large-Scede Physiced Containment Recommend at ions, 
the WOr)cing Group may request information from individuad companies. 
Since NIH is not a regulatory agency, the intent of ^u^y such informa- 
tion collection will be fact-finding, to help in development of 
gener^d reccrmendations from the working Group to the RAC, and not 
for purposes of regulatory actions directed at individuad companies." 
Dr. McKinney suggested that the working group might examine the question of 
medical surveillance. Mr. Pauker suggested that environmental monitoring 
as undertaJcen by companies might edso be examined; he said specific questions 
must be asked and a large data base accumulated. 
ar. Henry of the Food and Drug Administration (FDA) suggested the wor)ung group 
begin a preliminary consideration of the issue of medical surveillance. 
Dr. Mason suggested that medical surveillance might be quite costly and ques- 
tioned whether such expenditures were warranted. Dr. Richardson said a medical 
surveillance progrem might not prove too expensive if a select group of 
( 83 ) 
